FDA Adverse Event Injury Summary report: N

RENUVION

MDR report key: 15476014 · Received September 24, 2022

Report

Report Number
3007593903-2022-00017
Event Type
Injury
Date Received
September 24, 2022
Date of Event
February 24, 2022
Report Date
September 19, 2022
Manufacturer
APYX MEDICAL CORPORATION
Product Code
GEI
UDI-DI
00607151050153
PMA / PMN Number
K191542
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Description of Event or Problem · 0

PATIENT UNDERWENT VASER LIPOSUCTION FOLLOWED BY SUBDERMAL COAGULATION WITH RENUVION TO THE SUBMENTAL AREA. ONE PASS WITH RENUVION WAS PERFORMED AT GENERATOR SETTINGS OF 80% POWER AND 1.5 LITERS OF FLOW. SPEED, SPACING, INFILTRATION SOLUTION AND AMOUNT, TREATMENT PLANE DEPTHS, AND ASPIRATION AMOUNT WAS REQUESTED BUT NOTED AS UNKNOWN BY THE SURGEON'S OFFICE. PATIENT WORE A GARMENT POST PROCEDURE AND FOLLOWED AFTER CARE INSTRUCTIONS PER HER SURGEON'S PROTOCOL. HOWEVER, THREE DAYS POST PROCEDURE, A BURN TO THE TREATED AREA WAS NOTICED. THE DEGREE OF BURN WAS NOT CONFIRMED BY THE SURGEON. MULTIPLE STEROID INJECTIONS OF KENALOG WERE ADMINISTERED BY THE SURGEON TO THE AFFECTED AREA ON (B)(6) 2022. ADDITIONALLY, MICRO-NEEDLING WAS PERFORMED ON (B)(6) 2022 IN EFFORT TO TREAT THE BURN. ALTHOUGH THE SURGEON NOTED THAT THE PATIENT WAS HEALING, THE PATIENT HAS A VISIBLE SCAR POST PROCEDURE AND TREATMENTS AS A RESULT OF THE BURN. THE CAUSE OF THE BURN IS DUE TO END HITS. THE END HITS MAY HAVE BEEN CAUSED BY THE APYX MEDICAL DEVICE OR THE VASER DEVICE OR A COMBINATION OF BOTH DURING THE PROCEDURE. END HITS ARE NOT A RECOMMENDED TECHNIQUE PER THE APYX MEDICAL TECHNIQUE CONSIDERATIONS WHICH ARE DISCLOSED DURING CUSTOMER TRAINING. AS IT IS UNKNOWN IF THE END HITS WERE CAUSED OR CONTRIBUTED BY THE VASER DEVICE OR BY THE APYX MEDICAL DEVICE, THIS EVENT IS DEEMED REPORTABLE AS A USE ERROR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1651769 RENUVION RENUVION GEI APYX MEDICAL CORPORATION APYX-15-TP 00607151050153

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention| S VASER LIPOSUCTION